FinTrust Capital Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$45.4K Sell
136
-8
-6% -$3.04K 0.01% 593
2024
Q2
$59.3K Hold
144
0.01% 496
2024
Q1
$58.2K Sell
144
-8
-5% -$2.81K 0.01% 481
2023
Q4
$46.6K Buy
152
+29
+24% +$7.83K 0.01% 511
2023
Q3
$29.8K Buy
+123
New +$31.5K 0.01% 568

Other funds holding MEDP

FinTrust Capital Advisors's MEDP Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Medpace (MEDP) stake by 5.6% in Q3 2024, selling an estimated $3.04K and leaving 136 shares worth $45.4K. The position accounts for 0.01% of the portfolio, ranked #593.

FinTrust Capital Advisors first reported a position in MEDP in Q3 2023 and has held it in 5 quarters since. The position peaked at $59.3K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • FinTrust Capital Advisors held 136 shares of Medpace worth $45.4K as of Q3 2024.
  • FinTrust Capital Advisors sold 8 Medpace shares in Q3 2024, an estimated $3.04K.
  • Medpace made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #593 holding.
  • FinTrust Capital Advisors first reported a position in Medpace in Q3 2023 and has held it in 5 quarters since.
  • FinTrust Capital Advisors's Medpace position peaked at $59.3K in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.